Cadence Pharmaceuticals, Inc.Most RecentHealthcareWhy dividend recapitalization is the sweet spot for leveraged loansWhile M&A activity was still below market prospects, demand for dividend recapitalization deals was mostly strong last week.
HealthcareWhy dividend recapitalization is the sweet spot for leveraged loansWhile M&A activity was still below market prospects, demand for dividend recapitalization deals was mostly strong last week.
